Barinthus Biotherapeutics plc (BRNS) Tops Q3 EPS by 4c

Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q3 EPS of ($0.36), $0.04 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.

You May Also Be Interested In

• X Financial (XYF) Tops Q2 EPS by 438c
• Alibaba executives buy $15.3 million in shares after stock offering
• Spruce Biosciences BLA filing for rare disease drug on track for 2026